Ghrelin O-Acyltransferase Assays and Inhibition

Methods in Enzymology

Volumn 514, Issue , 2012, Pages 205-228

  Taylor, Martin S ^a   Hwang, Yousang ^a   Hsiao, Po Yuan ^a   Boeke, Jef D ^a   Cole, Philip A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bisubstrate; design; ELISA; inhibitor; mechanism; metabolism; octanoyl CoA; peptide; synthetic compound; weight

Indexed keywords

ACYLTRANSFERASE; ENZYME INHIBITOR; GHRELIN; GHRELIN O ACYLTRANSFERASE, MOUSE; GHRELIN O-ACYLTRANSFERASE, MOUSE; GHRELIN RECEPTOR; GHRELIN, DES N OCTANOYL; GHRELIN, DES-N-OCTANOYL; GO COA TAT; GO-COA-TAT; PEPTIDE;

ACYLATION; ANIMAL; BLOOD; BODY WEIGHT; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; METHODOLOGY; MOUSE; REVIEW; STRUCTURE ACTIVITY RELATION;

ACYLATION; ACYLTRANSFERASES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; ENZYME ACTIVATION; ENZYME ASSAYS; ENZYME INHIBITORS; GHRELIN; HUMANS; MICE; PEPTIDES; RECEPTORS, GHRELIN; STRUCTURE-ACTIVITY RELATIONSHIP;

MLCS; MLOWN;

EID: 84873146985     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381272-8.00013-1     Document Type: Chapter

References (85)

1. Andrews, Z.B., et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454 (2008), 846–851.
2. Barkan, A.L., et al. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J. Clin. Endocrinol. Metabol. 88 (2003), 2180–2184.
3. Barnett, B.P., et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 330 (2010), 1689–1692.
4. Bednarek, M.A., et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43 (2000), 4370–4376.
5. Bose, R., et al. Protein tyrosine kinase-substrate interactions. Curr. Opin. Struct. Biol. 16 (2006), 668–675.
6. Bricambert, J., et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 120 (2010), 4316–4331.
7. Buglino, J.A., Resh, M.D., Hhat is a palmitoylacyltransferase with specificity for N-palmitoylation of Sonic Hedgehog. J. Biol. Chem. 283 (2008), 22076–22088.
8. Buglino, J.A., Resh, M.D., Identification of conserved regions and residues within Hedgehog acyltransferase critical for palmitoylation of Sonic Hedgehog. PLoS One, 5, 2010, e11195.
9. Carlini, V.P., et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem. Biophys. Res. Commun. 299 (2002), 739–743.
10. Castaneda, T.R., et al. Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocrinol. 31 (2010), 44–60.
11. Cerchietti, L.C., et al. BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. J. Clin. Invest. 120 (2010), 4569–4582.
12. Chamoun, Z., et al. Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science 293 (2001), 2080–2084.
13. Chen, H.Y., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145 (2004), 2607–2612.
14. Cheng, K.Y., et al. The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. J. Biol. Chem. 281 (2006), 23167–23179.
15. Cleary, J., et al. p300/CBP-associated factor drives DEK into interchromatin granule clusters. J. Biol. Chem. 280 (2005), 31760–31767.
16. Clevers, H., Wnt/beta-catenin signaling in development and disease. Cell 127 (2006), 469–480.
17. Cowley, M.A., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 (2003), 649–661.
18. Date, Y., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000), 4255–4261.
19. de la Cour Dornonville, C., et al. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul. Pept. 120 (2004), 23–32.
20. De Vriese, C., et al. Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology 146 (2005), 1514–1522.
21. Dezaki, K., et al. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol. Ther. 118 (2008), 239–249.
22. Diano, S., et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9 (2006), 381–388.
23. Garner, A.L., Janda, K.D., cat-ELCCA: a robust method to monitor the fatty acid acyltransferase activity of ghrelin O-acyltransferase (GOAT). Angew. Chem. Int. Ed Engl. 49 (2010), 9630–9634.
24. Garner, A.L., Janda, K.D., A small molecule antagonist of ghrelin O-acyltransferase (GOAT). Chem. Commun. (Camb.) 47 (2011), 7512–7514.
25. Groschl, M., et al. Evaluation of the comparability of commercial ghrelin assays. Clin. Chem. 50 (2004), 457–458.
26. Guan, X.M., et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48 (1997), 23–29.
27. Guidez, F., et al. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25 (2005), 5552–5566.
28. Guo, Z.Y., et al. The active site His-460 of human acyl-coenzyme A: cholesterol acyltransferase 1 resides in a hitherto undisclosed transmembrane domain. J. Biol. Chem. 280 (2005), 37814–37826.
29. Gutierrez, J.A., et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. USA 105 (2008), 6320–6325.
30. Heller, R.S., et al. Genetic determinants of pancreatic epsilon-cell development. Dev. Biol. 286 (2005), 217–224.
31. Hines, A.C., Cole, P.A., Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A. Bioorg. Med. Chem. Lett. 14 (2004), 2951–2954.
32. Hines, A.C., et al. Bisubstrate analog probes for the insulin receptor protein tyrosine kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design. Bioorg. Chem. 33 (2005), 285–297.
33. Hofmann, K., A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem. Sci. 25 (2000), 111–112.
34. Howard, A.D., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996), 974–977.
35. Iwakura, H., et al. Establishment of a novel ghrelin-producing cell line. Endocrinology 151 (2010), 2940–2945.
36. Jencks, W.P., On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci. USA 78 (1981), 4046–4050.
37. Joseph, J.W., et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51 (2002), 3211–3219.
38. Kadowaki, T., et al. The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev. 10 (1996), 3116–3128.
39. Kamegai, J., et al. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 50 (2001), 2438–2443.
40. Kanamoto, N., et al. Substantial production of ghrelin by a human medullary thyroid carcinoma cell line. J. Clin. Endocrinol. Metabol. 86 (2001), 4984–4990.
41. Kirchner, H., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med. 15 (2009), 741–745.
42. Kojima, M., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999), 656–660.
43. Korbonits, M., et al. The growth hormone secretagogue receptor. Growth Horm. IGF Res. 9 (1999), 93–99.
44. Lau, O.D., et al. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol. Cell 5 (2000), 589–595.
45. Levinson, N.M., et al. A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol., 4, 2006, e144.
46. Liu, J., et al. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J. Clin. Endocrinol. Metabol. 93 (2008), 1980–1987.
47. Liu, X., et al. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451 (2008), 846–850.
48. Liu, Y., et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456 (2008), 269–273.
49. Marek, R., et al. Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300. J. Neurosci. 31 (2011), 7486–7491.
50. Medzihradszky, D., et al. Solid-phase synthesis of adenosine phosphopeptides as potential bisubstrate inhibitors of protein-kinases. J. Am. Chem. Soc. 116 (1994), 9413–9419.
51. Morton, G.J., Schwartz, M.W., The NPY/AgRP neuron and energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25 (2001), S56–S62.
52. Nishi, Y., et al. Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146 (2005), 2255–2264.
53. Nussbaum, S.R., et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem. 33 (1987), 1364–1367.
54. Ogiso, K., et al. Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia. J. Gastroenterol. Hepatol. 26 (2011), 67–72.
55. Oussaief, L., et al. Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation. J. Biol. Chem. 284 (2009), 23912–23924.
56. Pagac, M., et al. Topology of 1-acyl-sn-glycerol-3-phosphate acyltransferases SLC1 and ALE1 and related membrane-bound O-acyltransferases (MBOATs) of Saccharomyces cerevisiae. J. Biol. Chem. 286 (2011), 36438–36447.
57. Parang, K., et al. Mechanism-based design of a protein kinase inhibitor. Nat. Struct. Biol. 8 (2001), 37–41.
58. Pasca di Magliano, M., Hebrok, M., Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 3 (2003), 903–911.
59. Potocky, T.B., et al. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278 (2003), 50188–50194.
60. Prado, C.L., et al. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci. USA 101 (2004), 2924–2929.
61. Reya, T., Clevers, H., Wnt signalling in stem cells and cancer. Nature 434 (2005), 843–850.
62. Sagar, V., et al. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors. Bioorg. Med. Chem. 12 (2004), 3383–3390.
63. Satou, M., et al. Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 151 (2010), 4765–4775.
64. Schwarze, S.R., et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999), 1569–1572.
65. Shen, K., Cole, P.A., Conversion of a tyrosine kinase protein substrate to a high affinity ligand by ATP linkage. J. Am. Chem. Soc. 125 (2003), 16172–16173.
66. Spin, J.M., et al. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. PLoS One, 5, 2010, e14301.
67. Sun, Y., et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 3 (2006), 379–386.
68. Sun, Y., et al. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149 (2008), 843–850.
69. Takada, R., et al. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev. Cell 11 (2006), 791–801.
70. Takahashi, T., et al. Production of n-octanoyl-modified ghrelin in cultured cells requires prohormone processing protease and ghrelin O-acyltransferase, as well as n-octanoic acid. J. Biochem. 146 (2009), 675–682.
71. Tong, J., et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 59 (2010), 2145–2151.
72. Wang, L., et al. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science 333 (2011), 765–769.
73. Wierup, N., et al. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul. Pept. 107 (2002), 63–69.
74. Willesen, M.G., et al. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70 (1999), 306–316.
75. Yang, J., et al. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 (2008), 387–396.
76. Yang, J., et al. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proc. Natl. Acad. Sci. USA 105 (2008), 10750–10755.
77. Yi, C.X., et al. The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS One, 7, 2012, e32100.
78. Zhang, J.H., et al. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999), 67–73.
79. Zhang, C.Y., et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105 (2001), 745–755.
80. Zhao, C., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458 (2009), 776–779.
81. Zhao, T.J., et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc. Natl. Acad. Sci. USA 107 (2010), 7467–7472.
82. Zhao, T.J., et al. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proc. Natl. Acad. Sci. USA 107 (2010), 15868–15873.
83. Zheng, Y., et al. Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor. J. Am. Chem. Soc. 127 (2005), 17182–17183.
84. Zhou, A., et al. Proteolytic processing in the secretory pathway. J. Biol. Chem. 274 (1999), 20745–20748.
85. Zhu, X., et al. On the processing of proghrelin to ghrelin. J. Biol. Chem. 281 (2006), 38867–38870.